Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Evidence suggests that eosinophilic airway inflammation is important in the pathogenesis of severe chronic obstructive pulmonary disease (COPD) exacerbations. The present authors tested the hypothesis that a management strategy that aims to reduce sputum eosinophil counts is associated with a reduction in exacerbations of COPD. A total of 82 patients with COPD were randomised into two groups. One group was treated according to traditional guidelines (British Thoracic Society (BTS) group) and the other (sputum group) was treated with the additional aim of minimising eosinophilic airway inflammation, assessed using the induced sputum eosinophil count. The primary outcome was exacerbations, which were categorised as mild, moderate or severe. The frequency of severe exacerbations per patient per year was 0.5 and 0.2 in the BTS and sputum groups, respectively (mean reduction 62%). The majority of this benefit was confined to patients with eosinophilic airway inflammation. There was no difference in the frequency of mild and moderate exacerbations. The average daily dose of inhaled or oral corticosteroids during the trial did not differ between the groups. Out of 42 patients in the sputum group, 17 required regular oral corticosteroids to minimise eosinophilic airway inflammation. A management strategy that aims to minimise eosinophilic airway inflammation, as well as symptoms, is associated with a reduction in severe exacerbations of chronic obstructive pulmonary disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,814
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationA measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721 · cited 2×
“The present authors’ decisions about clinical control were based upon the patients’ response to a previously validated symptom VAS [ 17 ].”
MethodCalverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Davies, L., Angus, R., & Calverley, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11326-0 · Cited by 595
Brightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Self-citationAirway eosinophilia in chronic bronchitis during exacerbations.
Saetta, M., Di Stefano, A., Maestrelli, P., Turato, G., Ruggieri, M. P., Roggeri, A., Calcagni, P., Mapp, C. E., Ciaccia, A., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952628 · Cited by 536
Non-eosinophilic cor ticosteroid unresponsive asthma
Pavord, I. D., Brightling, C. E., Woltmann, G., & Wardlaw, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01813-9 · Cited by 528
Self-citationEfficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease
(1997) · Thorax · doi:10.1136/thx.52.2008.s1.5 · Cited by 446
The use of induced sputum to investigate airway inflammation
Pavord, I. D., Pizzichini, M. M., Pizzichini, E., & Hargreave, F. E. (1997) · Thorax · doi:10.1136/thx.52.6.498 · Cited by 420
Self-citationExhaled Nitric Oxide: A Predictor of Steroid Response
Smith, A. D., Cowan, J. O., Brassett, K. P., Filsell, S., McLachlan, C., Monti-Sheehan, G., Herbison, G. P., & Taylor, D. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1498oc · Cited by 371
Brightling, C. E. (2005) · Thorax · doi:10.1136/thx.2004.032516 · Cited by 369
Self-citationTreasure, T., & MacRae, K. D. (1998) · BMJ · doi:10.1136/bmj.317.7155.362 · Cited by 344
Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease
MAZIAK, W., LOUKIDES, S., CULPITT, S., SULLIVAN, P., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.97-05009 · Cited by 324
Jones, P. W., Willits, L. R., Burge, P. S., & Calverley, P. M. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00013303 · Cited by 249
Berry, M., Hargadon, B., Morgan, A., Shelley, M., Richter, J., Shaw, D., Green, R. H., Brightling, C., Wardlaw, A. J., & Pavord, I. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00132404 · Cited by 220
Self-citationRutgers, S. R., van der Mark, T. W., Coers, W., Moshage, H., Timens, W., Kauffman, H. F., Koeter, G. H., & Postma, D. S. (1999) · Thorax · doi:10.1136/thx.54.7.576 · Cited by 125
Brightling, C. E., Monterio, W., GREEN, R. H., Parker, D., Morgan, M. D. L., Wardlaw, A. J., & Pavord, I. D. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1195 · Cited by 109
Self-citationHospers, J. J., Schouten, J. P., Weiss, S. T., Rijcken, B., & Postma, D. S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9811041 · Cited by 104
Cited by
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Self-citationTreatable traits: toward precision medicine of chronic airway diseases
Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S., Humbert, M., Jones, P., Gibson, P. G., Vestbo, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01359-2015 · Cited by 1,083
Self-citationAfter asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Self-citationPascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Self-citationO’Donnell, D. E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Metadata
- Authors
- Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., & Pavord, I. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-02-14
- Volume
- 29
- Issue
- 5
- Pages
- 906-913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2166667839
- Cited by
- 453
- References
- 29
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.